06/21/2023
PSMA PET Imaging
PSMA PET is a newer, highly sensitive imaging scan that can detect prostate cancer metastases much earlier, when they are much smaller. It is approved for two types of patients: 1) patients with suspected prostate cancer metastasis who are potentially curable by surgery or radiation therapy (for example, patients newly. Read More
06/18/2023
Liquid Biopsy: Catching Cancer Cells in the Blood
Snapshot of Cancer Metastatic prostate cancer looks a lot different from cancer that is confined to the prostate. That’s because over time, as it develops the ability to spread beyond the prostate, cancer undergoes specific mutations. How has it changed? The answer to this question is important, but it would. Read More
06/16/2023
More benefits of a plant-based diet: Better sexual and urinary function
After a prostate cancer diagnosis, patients often wonder what they can do to reduce the chance of their cancer worsening or recurring, to improve their recovery after treatment, or simply to feel better and have more energy. Previous research has demonstrated that plant-based diets may reduce the risk of developing. Read More
06/15/2023
Colorful Summer Potluck Salad
PCF’s Home Run Challenge wraps on Father’s Day, which brings us to our final installment of Game Day recipes! Whether you’re celebrating with a family BBQ or having friends over after a day at the ballpark, this colorful summer salad is a hearty side dish. (For your BBQ main, try. Read More
06/01/2023
Breaking News: FDA Approves Combination of Olaparib + Abiraterone for Metastatic Castration-Resistant Prostate Cancer in Patients with BRCA Gene Mutations
The U.S. FDA has approved olaparib in combination with abiraterone (plus prednisone or prednisolone) for patients with metastatic castration-resistant prostate cancer (mCRPC) who also have a mutation in specific genes (BRCA1 and BRCA2). This means that patients with mCRPC (prostate cancer that has spread beyond the prostate and continues to. Read More
05/31/2023
Major League Baseball and Prostate Cancer Foundation Partner on 27th Annual Home Run Challenge and Tour
LOS ANGELES, Calif., May 31, 2023 – The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are teaming up for the 27th Annual Home Run Challenge and Tour now through Father’s Day, June 18, to raise funds and awareness in the fight against prostate cancer through America’s National Pastime.. Read More
05/30/2023
Prostate Cancer Survivorship, Part 1
Survivor. What does that word bring to mind? (Besides, of course, the name of the rock band whose song, “Eye of the Tiger,” went double-platinum in 1982 and was the theme of “Rocky III.”) There are more prostate cancer survivors now than ever before. More men are being. Read More
05/30/2023
Prostate Cancer Survivorship, Part 2
Matters of Survivorship: Sexual Health If you’re dealing with prostate cancer – the disease itself, or the aftermath of treatment – then you are dealing with issues of survivorship, says PCF-funded medical oncologist Alicia Morgans, M.D., M.P.H., Medical Director of Cancer Survivorship at Dana Farber Cancer Institute. Sexual health is. Read More
05/30/2023
Prostate Cancer Survivorship, Part 3
Matters of Survivorship: Fighting Back on ADT ADT will try to affect your overall health, but here’s the good news: you can fight back, says PCF-funded medical oncologist Alicia Morgans, M.D., M.P.H., Medical Director of Cancer Survivorship at Dana Farber Cancer Institute. Be aware of what it might do, and. Read More
05/25/2023
One-Year Update: A Beacon of Hope for Others
More than a year ago, Matt Fish kindly shared his remarkable story with PCF. A Veteran, Matt was diagnosed with prostate cancer at age 45. After a prostatectomy, his PSA remained high, and a PET scan showed that the cancer had spread to his hip. The cancer was advanced: Gleason. Read More